I-Mab Announces Upcoming Participation at January Conferences
- Friday, December 31, 2021, 8:10
- Finance
- Add a comment
SHANGHAI and GAITHERSBURG, MD., Dec. 31, 2021 /PRNewswire/ — I-Mab (the “Company”) (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced its participation in the following conferences…
About the Author
adminasapcorp has written 37652 stories on this site.